Soyacerebroside I

CAS: 114297-20-0

Ref. 3D-PEA29720

Información del producto

• Nombre: Soyacerebroside I
• Sinónimos: (2R)-N-[(1S,2R,3E,7E)-1-[(β-<span class="text-smallcaps">D</span>-Glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadien-1-yl]-2-hydroxyhexadecanamide, (2R)-N-[(1S,2R,3E,7E)-1-[(β-<span class="text-smallcaps">D</span>-Glucopyranosyloxy)methyl]-2-hydroxyheptadeca-3,7-dien-1-yl]-2-hydroxyhexadecanamide, (2R)-N-{(2R,3E,7E)-1-[(alpha-D-glucopyranosyloxy)methyl]-2-hydroxyheptadeca-3,7-dien-1-yl}-2-hydroxyhexadecanamide, (2S,3R,4E,8E)-1-O-β-<span class="text-smallcaps">D</span>-Glucopyranosyl-3-hydroxy-2-(2′R-hydroxypalmitoylamino)-4,8-octadecadiene, 1-O-Glucopyranosyl-2-N-(2'-hydroxypalmitoyl)octadecasphinga-4,8-dienine, 1-O-β-<span class="text-smallcaps">D</span>-Glucopyranosyl-(2S,3R,4E,8E)-2-[(2′R)-2-hydroxyhexadecanoylamino]-4,8-octadecadiene-1,3-diol, Hexadecanamide, N-(1-((beta-D-glucopyranosyloxy)methyl)-2-hydroxy-3,7-heptadecadienyl)-2-hydroxy-, (1S-(1R*(S*),2S*,3E,7E))-, Hexadecanamide, N-[(1S,2R,3E,7E)-1-[(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadien-1-yl]-2-hydroxy-, (2R)-, Hexadecanamide, N-[(1S,2R,3E,7E)-1-[(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadienyl]-2-hydroxy-, (2R)-, Hexadecanamide, N-[1-[(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadienyl]-2-hydroxy-, [1S-[1R*(S*),2S*,3E,7E]]-, Hexadecanamide, N-[(1S,2R,3E,7E)-1-[(β-D-glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadienyl]-2-hydroxy-, (2R)-, (2R)-N-[(1S,2R,3E,7E)-1-[(β-D-Glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadien-1-yl]-2-hydroxyhexadecanamide, Hexadecanamide, N-[1-[(β-D-glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadienyl]-2-hydroxy-, [1S-[1R*(S*),2S*,3E,7E]]-, Soya-cerebroside I, Hexadecanamide, N-[(1S,2R,3E,7E)-1-[(β-D-glucopyranosyloxy)methyl]-2-hydroxy-3,7-heptadecadien-1-yl]-2-hydroxy-, (2R)-

Descripción

Soyacerebroside I is a triterpenoid saponin that has potent tyrosinase inhibitory activity. It can be used as a potential therapeutic agent for the treatment of human liver cancer and other cancers, such as breast cancer. Soyacerebroside I inhibits the production of fatty acids in human liver cells, which may be due to its ability to suppress the activity of fatty acid synthase. This compound also inhibits tyrosinase-mediated melanogenesis and suppresses the growth of LPS-stimulated RAW 264.7 cells. In addition, soyacerebroside I has been shown to have anti-cancer effects against human liver cancer cells, including inducing apoptosis and inhibiting cell proliferation.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 714 g/mol
• Fórmula: C₄₀H₇₅NO₉
• Pureza: Min. 95%